We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Tries To Halt Apotex Pulmicort Launch

Law360 (April 7, 2009, 12:00 AM EDT) -- AstraZeneca Pharmaceuticals LP has asked a federal court to stop Canadian drugmaker Apotex Inc. from launching a generic version of children's asthma medication Pulmicort Respules, one week after the U.S. Food and Drug Administration gave Apotex permission to do so.

In a motion for interim relief filed late Monday in the U.S. District Court for the District of New Jersey, AstraZeneca asked the court to issue a temporary restraining order to bar Apotex from selling its generic version until AstraZeneca's patent infringement suit against the generic-drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.